Regulation of primary metastasis in high grade serous ovarian cancer
Regulation of primary metastasis in high grade serous ovarian cancer
批准号:
10608098
负责人:
Tova Bergsten
金额:
$5.27万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-16 至 2025-05-15
关键词:
AddressAdrenergic AgentsAdrenergic beta-AntagonistsAdverse effectsAnabolismAutomobile DrivingCRISPR/Cas technologyCancer BiologyCancer PatientCellsChemicalsChemopreventionClinicalClinical ManagementCoculture TechniquesCommunicationCuesDataDevelopmentDiagnosisDiseaseDisease ProgressionDistant MetastasisEarly InterventionEpithelial CellsEpitheliumEventFDA approvedGoalsHumanImmunotherapyInvadedLesionMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of ovaryMammalian OviductsMediatorMolecularMusMutationNeoplasm MetastasisNorepinephrineOsteonectinOutcomeOvarianOvaryPI3K/AKTPathway interactionsPatient CarePatientsPeritonealPharmaceutical PreparationsPhysiciansProductionPrognosisPropranololRadiation therapyRefractoryRegulationRestRoleScientistSeriesSerousSignal TransductionSoilSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSystemTP53 geneTechniquesTestingTimeTrainingTranslatingTumor PromotersTumor Suppressor ProteinsUp-RegulationWomanXenograft procedureadvanced diseaseantagonistbeta-2 Adrenergic Receptorsbeta-adrenergic receptorclinical practicecostdrug repurposingexpectationexperimental studyhigh riskimprovedimproved outcomeinhibitorinsightmalignant phenotypemass spectrometric imagingmigrationneoplastic cellnovel strategiesovarian neoplasmoverexpressionparacrinepharmacologicprecision medicinepreventreceptorrelease factorresponsesmall hairpin RNAstandard of caretumortumor progressiontumorigenic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
High grade serous ovarian cancer (HGSOC) is both the most common and most lethal ovarian cancer
histotype. Though HGSOC has been long thought to originate in the ovary, recent evidence now suggests that
HGSOC precursor lesions in fact originate in the fallopian tube. Further, select dysplastic cells from the
fallopian tube disseminate from these precursor lesions and follow a variety of local migratory cues in order to
colonize the ovary and establish a primary HGSOC tumor. The ovary seems to facilitate the expansion and
spread of the ovary to the rest of the peritoneal space. Though this phenomenon is well documented, the
molecular mechanisms that drive the initial dissemination of dysplastic fallopian tube cells to the ovary are
poorly understood. To address this, our group has developed a new imaging mass spectrometry technique that
has allowed for unprecedented insight into the paracrine factors that create a pro-metastatic niche and allow
for the migration of fallopian tube cells toward the ovary. Using this technique, we determined that co-culture of
murine ovary explants with dysplastic tubal cells leads to consistent increases in norepinephrine secretion from
the ovary, later found to be produced by the ovary itself. This is significant, as norepinephrine is an established
tumor promoter in advanced disease, and ovarian cancer patients taking β-blockers that interfere with
norepinephrine signals typically have improved clinical outcomes. However, the role of norepinephrine in tumor
development is largely unknown. Given the wide availability, low cost, and minimal adverse effects of β-
blockers, should norepinephrine similarly enhance the development of HGSOC this may provide opportunity
for early intervention and/or chemoprevention in high-risk patients. Given the potential to directly impact clinical
practice, it is essential to further dissect both the mechanisms that direct norepinephrine biosynthesis, as well
as the downstream effects of norepinephrine during HGSOC development. Through the experiments detailed
in this proposal, we will gain valuable insight into these events in hopes of either preventing or delaying
HGSOC development in high-risk patients.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fcell.2022.1042734
发表时间:
2022
期刊:
Frontiers in cell and developmental biology
影响因子:
5.5
作者:
[]
通讯作者:
DOI:
10.1021/jasms.2c00044
发表时间:
2022-07-06
期刊:
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
影响因子:
3.2
作者:
[Lusk, Hannah J., Levy, Sarah E., Bergsten, Tova M., Burdette, Joanna E., Sanchez, Laura M.]
通讯作者:
Sanchez, Laura M.
DOI:
10.3390/nu15061407
发表时间:
2023-03-15
期刊:
Nutrients
影响因子:
5.9
作者:
[Bergsten TM, Li K, Lantvit DD, Murphy BT, Burdette JE]
通讯作者:
Burdette JE
Regulation of primary metastasis in high grade serous ovarian cancer
-
批准号:10368940
-
项目类别:
-
资助金额:$5.18万
-
财政年份:2021
-
负责人:Tova Bergsten
-
依托单位:
Regulation of primary metastasis in high grade serous ovarian cancer
-
批准号:10229162
-
项目类别:
-
资助金额:$5.1万
-
财政年份:2021
-
负责人:Tova Bergsten
-
依托单位:
海外基金